VEGFC and neoplasm: Together, this study indicates that the anti-tumor survival benefit observed from VEGF-C therapy could be the result of the increase in antigen-loaded DC migration from the CNS, not simply increased soluble antigen drainage from the bulk expansion of meningeal lymphatic vessels.